Sentence examples for relapse incidence from inspiring English sources

The evolution of the leukemic clones might serve as a potential explanation for differences in relapse incidence.

A surgical technique has been designed to overcome this high relapse incidence.

Even if not reaching statistical significance, differences in relapse incidence, DFS, and overall survival observed between both randomization arms in the nested case control analysis looked more impressive than those observed in the intent-to-treat analysis.

Furthermore, we identified a moderate negative correlation ρ = −0.48 [−0.65; −0.26] between the NPM1 level after primary treatment (n) and the time until relapse (d), pointing toward the already known prognostic value of NPM1 levels for relapse incidence [3,4,5,6] (Supplementary Figure S3C).

Patients with favorable/intermediate cytogenetics at diagnosis (n = 49) and patients with unfavorable cytogenetics at diagnosis but without a persistent abnormal clone at allo-HSCT (n = 83) had a similar 3-year leukemia-free survival of 58%-60% despite the higher 3-year relapse incidence (RI) in the latter group (32.3%, versus 16.8% in the former group).

The relapse incidence was low but strategies to ameliorate TRM are needed.

The placebo group, in line with the existing knowledge of how the relapse history works in relation to future relapses in MS patients (contagion phenomenon), showed the expected trend of increased relapse incidences.

However, this assumption may not always be correct, in Canada for example Layton and Barbeau determined that switching patients from original to generic clozapine would lead to no cost savings if it were accompanied by an 11.2% relapse incidences caused by the change [ 6].

Relapse Cumulative Incidence were obtained through Kaplan-Meier estimates and the difference between two curves was assessed by log rank test.

A threshold was deemed valid only if the difference in the Relapse Cumulative Incidence curves was statistically significant (CYCLIN E threshold 1.228, log rank test after Bonferroni corrections p = 0.000075) (Figure 4A).

Primary endpoints included overall survival (OS), disease-free survival (DFS), relapse (cumulative incidence of relapse, CIR), non-relapse mortality (NRM) and engraftment.